Literature DB >> 25869658

Feasibility and Safety of Intradialysis Yoga and Education in Maintenance Hemodialysis Patients.

Gurjeet S Birdee1, Russell L Rothman2, Stephanie J Sohl3, Dolphi Wertenbaker4, Amy Wheeler5, Chase Bossart4, Oluwaseyi Balasire2, T Alp Ikizler6.   

Abstract

OBJECTIVE: Patients with end-stage renal disease on maintenance hemodialysis are much more sedentary than healthy individuals. The purpose of this study was to assess the feasibility and safety of a 12-week intradialysis yoga intervention versus a kidney education intervention on the promotion of physical activity. DESIGN AND METHODS: We randomized participants by dialysis shift to either 12-week intradialysis yoga or an educational intervention. Intradialysis yoga was provided by yoga teachers to participants while receiving hemodialysis. Participants receiving the 12-week educational intervention received a modification of a previously developed comprehensive educational program for patients with kidney disease (Kidney School). The primary outcome for this study was feasibility based on recruitment and adherence to the interventions and safety of intradialysis yoga. Secondary outcomes were to determine the feasibility of administering questionnaires at baseline and 12 weeks including the Kidney Disease-Related Quality of Life-36.
RESULTS: Among 56 eligible patients who approached for the study, 31 (55%) were interested and consented to participation, with 18 assigned to intradialysis yoga and 13 to the educational program. A total of 5 participants withdrew from the pilot study, all from the intradialysis yoga group. Two of these participants reported no further interest in participation. Three withdrawn participants switched dialysis times and therefore could no longer receive intradialysis yoga. As a result, 13 of 18 (72%) and 13 of 13 (100%) participants completed 12-week intradialysis yoga and educational programs, respectively. There were no adverse events related to intradialysis yoga. Intervention participants practiced yoga for a median of 21 sessions (70% participation frequency), with 60% of participants practicing at least 2 times a week. Participants in the educational program completed a median of 30 sessions (83% participation frequency). Of participants who completed the study (n = 26), baseline and 12-week questionnaires were obtained from 85%.
CONCLUSIONS: Our pilot study of 12-week intradialysis yoga and 12-week educational intervention reached recruitment goals but with less than targeted completion and adherence to intervention rates. This study provided valuable feasibility data to increase follow-up and adherence for future clinical trials to compare efficacy.
Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25869658      PMCID: PMC4863695          DOI: 10.1053/j.jrn.2015.02.004

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  40 in total

1.  K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.

Authors: 
Journal:  Am J Kidney Dis       Date:  2005-04       Impact factor: 8.860

Review 2.  Yoga for anxiety: a systematic review of the research evidence.

Authors:  G Kirkwood; H Rampes; V Tuffrey; J Richardson; K Pilkington
Journal:  Br J Sports Med       Date:  2005-12       Impact factor: 13.800

3.  Effects of aerobic exercise training and yoga on the baroreflex in healthy elderly persons.

Authors:  A J Bowman; R H Clayton; A Murray; J W Reed; M M Subhan; G A Ford
Journal:  Eur J Clin Invest       Date:  1997-05       Impact factor: 4.686

4.  Effectiveness of yoga therapy as a complementary treatment for major psychiatric disorders: a meta-analysis.

Authors:  Patricia Cabral; Hilary B Meyer; Donna Ames
Journal:  Prim Care Companion CNS Disord       Date:  2011

5.  The effects of yoga on psychosocial variables and exercise adherence: a randomized, controlled pilot study.

Authors:  Stephanie Bryan; Genevieve Pinto Zipp; Raju Parasher
Journal:  Altern Ther Health Med       Date:  2012 Sep-Oct       Impact factor: 1.305

6.  Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system.

Authors:  S B Yellen; D F Cella; K Webster; C Blendowski; E Kaplan
Journal:  J Pain Symptom Manage       Date:  1997-02       Impact factor: 3.612

7.  Association between physical performance and all-cause mortality in CKD.

Authors:  Baback Roshanravan; Cassianne Robinson-Cohen; Kushang V Patel; Ernest Ayers; Alyson J Littman; Ian H de Boer; T Alp Ikizler; Jonathan Himmelfarb; Leslie I Katzel; Bryan Kestenbaum; Stephen Seliger
Journal:  J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 10.121

8.  Randomized phase II trial of either fluorouracil, parenteral hydroxyurea, interferon-alpha-2a, and filgrastim or doxorubicin/docetaxel in patients with advanced gastric cancer with quality-of-life assessment: eastern cooperative oncology group study E6296.

Authors:  Scott Wadler; Carlos Brain; Paul Catalano; Avi I Einzig; David Cella; Al B Benson
Journal:  Cancer J       Date:  2002 May-Jun       Impact factor: 3.360

9.  Complementary and alternative medicine use among adults and children: United States, 2007.

Authors:  Patricia M Barnes; Barbara Bloom; Richard L Nahin
Journal:  Natl Health Stat Report       Date:  2008-12-10

10.  Use of Complementary and Alternative Medicine among Patients with End-Stage Renal Disease.

Authors:  Gurjeet S Birdee; Russell S Phillips; Robert S Brown
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-23       Impact factor: 2.629

View more
  2 in total

1.  Cerebral Perfusion in Hemodialysis Patients: A Feasibility Study.

Authors:  Jessica Anne Vanderlinden; Rachel Mary Holden; Stephen Harold Scott; John Gordon Boyd
Journal:  Can J Kidney Health Dis       Date:  2021-05-06

2.  Yoga Therapy in Children with Cystic Fibrosis Decreases Immediate Anxiety and Joint Pain.

Authors:  Christopher McNamara; Mahrya Johnson; Lisa Read; Heidi Vander Velden; Megan Thygeson; Meixia Liu; Laura Gandrud; John McNamara
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-19       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.